<div id="readability-page-1"><article><div>, /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:<ul type="disc"><li>46th Annual TD Cowen Healthcare Conference in Boston, on Monday, March 2, 2026, at 9:50 a.m. ET.</li><li>Leerink Partners Global Healthcare Conference in Miami, on Tuesday, March 10, 2026, at 8:00 a.m. ET.</li></ul>These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.About InsmedInsmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inﬂammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.Contact:Investors: Bryan Dunn Vice President, Investor Relations (646) 812-4030 investor.relations@insmed.comMedia: Claire Mulhearn Vice President, Corporate Communications (862) 842-6819 media@insmed.com<img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2544698/Insmed_Incorporated_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="400" height="186" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2544698/Insmed_Incorporated_Logo.jpg"/>SOURCE Insmed Incorporated</div></article></div>

Insmed Incorporated (Nasdaq: INSM) announced its participation in two upcoming investor conferences: the 46th Annual TD Cowen Healthcare Conference in Boston on March 2, 2026, and the Leerink Partners Global Healthcare Conference in Miami on March 10, 2026. Both events will be webcast live and archived for 30 days. Insmed focuses on developing therapies for serious diseases, particularly in pulmonary and inflammatory conditions, and has been recognized as a top employer in the biopharmaceutical industry.

StockTitan

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

VG Health

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

Invesco Dorsey Wright Healthcare Momentum ETF

VanEck Biotech ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

Insmed

Insmed To Present at March 2026 Investor Conferences | INSM Stock News